Biventricular Alternative Pacing (NCT00559143) | Clinical Trial Compass
WithdrawnPhase 4
Biventricular Alternative Pacing
Stopped: No patients enrolled for long period of time. No scientific interest any more
Greece38 participantsStarted 2007-11
Plain-language summary
Aim of present study is to examine the short and long-term results of pacing from right ventricular apex and to compare them with those of biventricular pacing.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Subjects between the age of 18 to 75 years with classic indication for permanent artificial pacing in which it is expected very high percentage of ventricular pacing, (pacing systoles constitute the 80% and more of the total).
* Physiologic or mildly affected systolic function of left ventricle, LVEF\> 40%.
* Subject is willing and able to comply with the Clinical Investigational Plan and to remain available for follow-up visits, through study closure.
* Subject (or if allowed by local law/regulations: subject's legally authorised representative) is willing and able to sign and date the study Informed Consent.
Exclusion Criteria:
* Subjects with classic indication for Biventricular Pacing - (European Guidelines 2007).
* Permanent atrial fibrillation.
* Cardiovascular surgery within the last three months prior to enrollment.
* Myocardial infarction within the last three months prior to enrollment.
What they're measuring
1
Change in End Diastolic Diameter of Left Ventricle with the two different ways of pacing (DDD(R)-RV & DDD(R)-BiV)